Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous…
New York City, NY, Nov. 01, 2025 (GLOBE NEWSWIRE) -- Introduction – Is Poor Sleep Ruining Your Days? If you’ve…